Pharmacogenetics of Nicotine Metabolism in Twins: Methods and Procedures
- 1 October 2004
- journal article
- Published by Cambridge University Press (CUP) in Twin Research
- Vol. 7 (05), 435-448
- https://doi.org/10.1375/twin.7.5.435
Abstract
This article describes a pharmacogenetic investigation of nicotine metabolism in twins. One hundred and thirty-nine twin pairs (110 monozygotic and 29 dizygotic) were recruited and assessed for smoking status, zygosity, and health conditions known or suspected to affect drug metabolism. Participants underwent a 30-minute infusion of stable isotope-labeled nicotine and its major metabolite, cotinine, followed by an 8-hour in-hospital stay. Blood and urine samples were taken at regular intervals for analysis of nicotine, cotinine, and metabolites by gas chromatography–mass spectrometry or liquid chromatography–mass spectrometry and subsequent characterization of pharmacokinetic phenotypes. DNA was genotyped to confirm zygosity and for variation in the primary gene involved in nicotine metabolism, CYP2A6. Univariate and multivariate biometric analyses planned for the future will determine genetic and environmental influences on each pharmacokinetic measure individually and in combination with each other, and in the presence and absence of covariates, including measured genotype. When the analyses are completed, this study will result in a more complete characterization of the impact of genetic and environmental influences on nicotine and cotinine metabolic pathways than has heretofore been reported. The approach taken, with its use of a quantitative model of nicotine metabolism, highly refined metabolic phenotypes, measured genotype, and advanced tools for biometric genetic analysis, provides a model for the use of twins in next-generation studies of complex drug-metabolism phenotypes.Keywords
This publication has 49 references indexed in Scilit:
- Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokersTobacco Control, 2004
- A meta-analytic review of the CYP2A6 genotype and smoking behaviorNicotine & Tobacco Research, 2004
- Whole Deletion of CYP2A6 Gene (CYP2A6*4C) and Smoking BehaviorNeuropsychobiology, 2004
- Chinese National Twin Registry as a Resource for Genetic Epidemiologic Studies of Common and Complex Diseases in ChinaTwin Research, 2002
- Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activityHuman Mutation, 2002
- An in Vivo Pilot Study Characterizing the New CYP2A6*7, *8, and *10 AllelesBiochemical and Biophysical Research Communications, 2002
- Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humansChemico-Biological Interactions, 1995
- Genetic Influence on Smoking — A Study of Male TwinsThe New England Journal of Medicine, 1992
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- Recruitment bias in twin research: The rule of two-thirds reconsideredBehavior Genetics, 1987